Work

A phase 1 trial of XK469: Toxicity profile of a selective topoisomerase IIβ inhibitor

Year: 2006

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-006-9024-5

Authors: Amin M. Alousi, Ramesh Boinpally, Richard Wiegand, Ralph Parchment, Shirish Gadgeel, Lance K. Heilbrun, Antionette J. Wozniak, Pamela DeLuca, Patricia M. LoRusso

Institutions: Wayne State University, The Barbara Ann Karmanos Cancer Institute

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Award: G293200927

OpenAlex ID: W2076492841

FWCI: 0.492

Cites: 16

Cited by: 28

Related to: 10